Gil Blum
Stock Analyst at Needham
(4.66)
# 236
Out of 4,496 analysts
262
Total ratings
57.75%
Success rate
26.16%
Average return
Main Sectors:
Top Industries:
22 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRIX Nurix Therapeutics | Maintains: Buy | $31 → $29 | $20.78 | +39.56% | 17 | Jul 12, 2024 | |
| RNAC Cartesian Therapeutics | Reiterates: Buy | $42 | $16.16 | +159.90% | 5 | Jul 8, 2024 | |
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $53 → $52 | $22.82 | +127.87% | 14 | Jun 28, 2024 | |
| NKTX Nkarta | Reiterates: Buy | $13 | $6.21 | +109.34% | 12 | Jun 28, 2024 | |
| SRPT Sarepta Therapeutics | Reiterates: Buy | n/a | $145.61 | - | 22 | Jun 27, 2024 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $88 | $54.56 | +61.29% | 15 | Jun 27, 2024 | |
| RXRX Recursion Pharmaceuticals | Reiterates: Buy | $17 | $7.61 | +123.39% | 15 | Jun 25, 2024 | |
| GTHX G1 Therapeutics | Maintains: Buy | $12 → $6 | $3.63 | +65.29% | 17 | Jun 25, 2024 | |
| TSHA Taysha Gene Therapies | Reiterates: Buy | $7 | $2.14 | +227.10% | 18 | Jun 19, 2024 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $9 | $4.25 | +111.76% | 19 | Jun 17, 2024 | |
| STTK Shattuck Labs | Maintains: Buy | $12 → $8 | $4.40 | +81.82% | 12 | Jun 14, 2024 | |
| MREO Mereo BioPharma Group | Maintains: Buy | $6 → $7 | $3.88 | +80.41% | 11 | Jun 12, 2024 | |
| GERN Geron | Maintains: Buy | $5 → $6 | $4.60 | +30.43% | 16 | Jun 7, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $81 | $39.78 | +103.62% | 7 | Jun 3, 2024 | |
| CELC Celcuity | Maintains: Buy | $24 → $23 | $17.28 | +33.10% | 10 | May 31, 2024 | |
| GBIO Generation Bio Co. | Reiterates: Buy | $10 | $2.88 | +247.22% | 11 | May 14, 2024 | |
| TCRX TScan Therapeutics | Reiterates: Buy | $11 | $6.92 | +58.96% | 1 | May 13, 2024 | |
| ACLX Arcellx | Reiterates: Buy | $81 | $62.56 | +29.48% | 16 | May 10, 2024 | |
| FOLD Amicus Therapeutics | Reiterates: Hold | n/a | $10.38 | - | 2 | May 10, 2024 | |
| NXTC NextCure | Reiterates: Buy | $4 | $1.69 | +136.69% | 8 | May 3, 2024 | |
| IMAB I-Mab | Reiterates: Buy | $6 | $1.43 | +319.58% | 12 | Apr 12, 2024 | |
| FATE Fate Therapeutics | Reiterates: Hold | n/a | $4.27 | - | 2 | Apr 11, 2024 |
Nurix Therapeutics
Jul 12, 2024
Maintains: Buy
Price Target: $31 → $29
Current: $20.78
Upside: +39.56%
Cartesian Therapeutics
Jul 8, 2024
Reiterates: Buy
Price Target: $42
Current: $16.16
Upside: +159.90%
Rocket Pharmaceuticals
Jun 28, 2024
Maintains: Buy
Price Target: $53 → $52
Current: $22.82
Upside: +127.87%
Nkarta
Jun 28, 2024
Reiterates: Buy
Price Target: $13
Current: $6.21
Upside: +109.34%
Sarepta Therapeutics
Jun 27, 2024
Reiterates: Buy
Price Target: n/a
Current: $145.61
Upside: -
CRISPR Therapeutics AG
Jun 27, 2024
Reiterates: Buy
Price Target: $88
Current: $54.56
Upside: +61.29%
Recursion Pharmaceuticals
Jun 25, 2024
Reiterates: Buy
Price Target: $17
Current: $7.61
Upside: +123.39%
G1 Therapeutics
Jun 25, 2024
Maintains: Buy
Price Target: $12 → $6
Current: $3.63
Upside: +65.29%
Taysha Gene Therapies
Jun 19, 2024
Reiterates: Buy
Price Target: $7
Current: $2.14
Upside: +227.10%
Autolus Therapeutics
Jun 17, 2024
Reiterates: Buy
Price Target: $9
Current: $4.25
Upside: +111.76%
Shattuck Labs
Jun 14, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $4.40
Upside: +81.82%
Mereo BioPharma Group
Jun 12, 2024
Maintains: Buy
Price Target: $6 → $7
Current: $3.88
Upside: +80.41%
Geron
Jun 7, 2024
Maintains: Buy
Price Target: $5 → $6
Current: $4.60
Upside: +30.43%
Immunocore Holdings
Jun 3, 2024
Reiterates: Buy
Price Target: $81
Current: $39.78
Upside: +103.62%
Celcuity
May 31, 2024
Maintains: Buy
Price Target: $24 → $23
Current: $17.28
Upside: +33.10%
Generation Bio Co.
May 14, 2024
Reiterates: Buy
Price Target: $10
Current: $2.88
Upside: +247.22%
TScan Therapeutics
May 13, 2024
Reiterates: Buy
Price Target: $11
Current: $6.92
Upside: +58.96%
Arcellx
May 10, 2024
Reiterates: Buy
Price Target: $81
Current: $62.56
Upside: +29.48%
Amicus Therapeutics
May 10, 2024
Reiterates: Hold
Price Target: n/a
Current: $10.38
Upside: -
NextCure
May 3, 2024
Reiterates: Buy
Price Target: $4
Current: $1.69
Upside: +136.69%
I-Mab
Apr 12, 2024
Reiterates: Buy
Price Target: $6
Current: $1.43
Upside: +319.58%
Fate Therapeutics
Apr 11, 2024
Reiterates: Hold
Price Target: n/a
Current: $4.27
Upside: -